课题基金 / 基金详情

Identification of the inhibitory factor for the transcription of inflammatory genes in vascular smooth muscle cells

Identification of the inhibitory factor for the transcription of inflammatory genes in vascular smooth muscle cells
血管平滑肌细胞炎症基因转录抑制因子的鉴定
批准号:
16590877
负责人:
NISHIO Yoshihiko
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

NISHIO Yoshihiko的其他基金

相似基金

相关文献

中文摘要
翻译
我们已报道,通过膜靶向p110CAAX的过度表达慢性激活磷脂酰肌醇3-激酶(PI3K),通过诱导CCAAT/增强子结合蛋白-β(C/eBP-β)和C/eBP-δ诱导大鼠血管平滑肌细胞(VSMC)的促炎基因表达。为探讨一氧化氮(NO)对促炎症基因表达的影响,我们观察了硝普钠(SNP)对PI3K慢性激活的VSMC单核细胞趋化蛋白-1(MCP-1)基因表达的影响。低浓度(0.05 mM)的SNP可显著降低MCP-1mRNA和蛋白的表达及其转录活性,而高浓度(0.5-1.0 mM)的SNP对MCP-1的转录活性无影响。我们发现,SNP诱导C/EBP同源蛋白(CHOP)表达,抑制C/EBP结合活性,并以剂量依赖的方式降低PI3K慢性激活所诱导的C/EBP活性,最大剂量可达1.0 mM。一致地,CHOP表达的增加显著降低了PI3K诱导的MCP-1启动子活性。然而,CHOP单独过表达可剂量依赖性地上调MCP-1启动子的活性,直至高浓度。MCP-1启动子缺失分析和凝胶迁移率改变分析表明,CHOP-RE位于MCP-1启动子-190~-179碱基之间。以CHOP-RE为诱饵,可显著抑制CHOP或SNP诱导的MCP-1启动子活性的升高。因此,NO供体诱导的CHOP对MCP-1基因表达具有双向作用:通过抑制C/EBPs降低基因表达,通过CHOP-RE促进基因表达。
英文摘要
We have reported that chronic activation of phosphatidylinositol 3-kinase (PI3K) by the overexpression of membrane-targeted p110CAAX induces proinflammatory gene expression in rat vascular smooth muscle cells (VSMCs) through the induction of CCAAT/enhancer binding protein-β (C/EBP-β) and C/EBP-δ. To examine the antiinflammatory effect of nitric oxide (NO) on the proinflammatory gene expression, we investigated the effects of sodium nitroprusside (SNP) on the monocyte chemoattractant protein-1 (MCP-1) gene expression in VSMCs under chronic activation of PI3K. At low concentration (0.05 mM) of SNP, but not at high concentration (0.5-1.0 mM), it significantly reduced MCP-1 mRNA and protein expression as well as its transcriptional activity. We found that SNP induced C/EBP homologous protein (CHOP) expression, which inhibited C/EBP binding activity and reduced the C/EBP activity induced by chronic activation of PI3K in a dose-dependent manner up to 1.0 mM. Consistently, the increase in CHOP expression significantly reduced the MCP-1 promoter activity induced by PI3K. However, the overexpression of CHOP alone up-regulated MCP-1 promoter activity in a dose-dependent manner up to high concentration. Deletion analysis of MCP-1 promoter and electrophoretic mobility shift assay identified the CHOP-response element (CHOP-RE) at the region between -190 and -179 bp of MCP-1 promoter. By CHOP-RE used as a decoy, the increase in promoter activity of MCP-1 induced by either CHOP or SNP was suppressed significantly. Thus, CHOP induced by an NO-donor has bidirectional effects on MCP-1 gene expression : it decreases the gene expression by inhibition of C/EBPs, and it increases the gene expression through the CHOP-RE.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
Mitochondorial Pathogenesis
线粒体发病机制
DOI: --
发表时间: 2004
期刊:
影响因子: --
作者: [Nagata R, Nishio Y et al., Tsuchiya M et al., Hashimoto T et al., Nishio Y et al.]
通讯作者: Nishio Y et al.
DOI: 10.2337/diacare.27.10.2409
发表时间: 2004-10
期刊: Diabetes care
影响因子: 16.2
作者: [M. Tsuchiya;E. Suzuki;K. Egawa;Y. Nishio;H. Maegawa;S. Inoue;K. Mitsunami;S. Morikawa;T. Inubushi;A. Kashiwagi]
通讯作者: M. Tsuchiya;E. Suzuki;K. Egawa;Y. Nishio;H. Maegawa;S. Inoue;K. Mitsunami;S. Morikawa;T. Inubushi;A. Kashiwagi
The transcription factor AP-2beta causes cell enlargement and insulinresistance in 3T3-L1 adipocytes.
转录因子 AP-2beta 导致 3T3-L1 脂肪细胞细胞增大和胰岛素抵抗。
DOI: --
发表时间: 2006
期刊: Endocrinology 147
影响因子: --
作者: [Tao Y, Maegawa H, Ugi S, 他]
通讯作者:
Supplement of tetrahydrobiopterin by a gene transfer of GTP cyclohydrolase IcDNA improves vascular dysfunction in insulin-resistant rats.
通过 GTP 环化水解酶 IcDNA 基因转移补充四氢生物蝶呤可改善胰岛素抵抗大鼠的血管功能障碍。
DOI: --
发表时间: 2005
期刊: J Cardiovasc Pharmacol 46
影响因子: --
作者: [Shinozaki K, Nishio Y, Yoshida Y, Koya D, Ayajiki K, Masada M, Kashiwagi A, Okamura T]
通讯作者: Okamura T
9
    The effects of omega-3 PUFA on vascular function
    • 批准号:
      23591336
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      NISHIO Yoshihiko
    • 依托单位:
    Identification and characterization of a new factor regulating SREBP-1c gene in liver.
    • 批准号:
      20591058
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      NISHIO Yoshihiko
    • 依托单位:
    Elucidation of the mechanism for the activation of transcription factors and gene response in the aorta of the Postprandial state of rata
    • 批准号:
      18590981
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.51万
    • 财政年份:
      2006
    • 负责人:
      NISHIO Yoshihiko
    • 依托单位:
    A novel effect of insulin on vascular smooth muscle cells through the transcriptional regulation ?the meaning of the activation of C/EBP
    • 批准号:
      14571090
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2002
    • 负责人:
      NISHIO Yoshihiko
    • 依托单位:
    国内基金
    海外基金
    槲皮素肠道菌群代谢产物3,4-二羟基苯乙酸负向调控PERK/eIF2α/CHOP轴抑制肺泡巨噬细胞METs形成改善急性肺损伤
    • 批准号:
      2026JJ50305
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      潘频华
    • 依托单位:
    TUDCA调控内质网应激PERK-ATF4-CHOP通路改善肿瘤恶病质肌萎缩的作用机制研究
    • 批准号:
      JCZRLH202601113
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    从肠道菌群-胆汁酸-内质网应激轴研究胃苓汤调控PERK-eIF2α-ATF4-CHOP通路干预脾虚湿盛证UC的机制
    • 批准号:
      2026JJ81066
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      蔡莹
    • 依托单位:
    PERK/eIF2α/ATF4/CHOP信号传导通路参与异丙肾上腺素诱导病理性心肌细胞肥大的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      陈丹琦
    • 依托单位: